Vera’s Atacicept Sets A New Efficacy Bar With Phase III Results In IgAN

First-In-Class Drug Exceeds Expectations

 
• By Mandy Jackson
  
Vera plans to develop atacicept in other indications, including kidney diseases beyond IgAN (Shutterstock)

More from Clinical Trials

More from Scrip